Xyosted Subcutaneous TRT Efficacy and Safety in Phase 3 Trials Estimated reading time: 8 minutes Key takeaways Phase 3 trials (QST‑13‑003, QST‑15‑005) showed a 90% responder rate achieving…
Stopping TRT Effects on LUTS PSA and Metabolic Markers Estimated reading time: 8 minutes Key takeaways Pausing TRT often reverses gains in LUTS, sexual function, and global symptoms;…
GLP-1RAs Preserve Gonadotropins and Sperm Parameters vs TRT Estimated reading time: 10 minutes GLP-1RAs may support testosterone while preserving LH and FSH, unlike TRT which suppresses both. Learn…